In the MC38 mouse tumor model, dual PD-1/TIM-3 blockade increases the expression of LAG-3 in T cells, and LAG-3 expression confers resistance to αPD-1/αTIM-3 treatment (73). The gene discussed is HAVCR2; the disease is neoplasm.